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ALCOHOL USE REDUCTION IN
THE COURSE OF SMOKING
CESSATION TREATMENT:
A REVIEW
Robert F. Leeman
Stephanie S. O’Malley
Yale University School of Medicine

Abstract
Given the well-established links between smoking and
alcohol consumption, we began a literature review to
assess the following: 1. the extent to which findings
from clinical trials of nicotine replacement therapy
(NRT) can be generalized to those with a current/past
history of alcohol use disorders; 2. whether alcohol
status affects smoking cessation outcome and 3.
effects of smoking cessation on alcohol use. Just over
half of the reports reviewed made mention of alcoholrelated inclusion/exclusion criteria, with abuse being
the most common criterion. Inclusion/exclusion
criteria we described ambiguously in a high percentage
of reports. Few studies reported any kind of findings
concerning links between alcohol consumption and
smoking cessation.

Introduction
 There is strong evidence of
co-morbidity between smoking and
alcohol use
 Evidence from animal and human
research points to common genetic
and biochemical underpinnings for
tobacco and alcohol use/dependence
 These findings have stimulated recent
interest in implications for treatment

Co-Morbidity
 44% of those who smoked in the last month reported at
least one binge drinking episode during same time
period1
 An estimated 74%-88% of those with substance abuse
problems are also smokers2
 Approximately 35% of those with alcohol use disorders
can also be classified as nicotine dependent3
 College student smokers are about 5 times more likely
than non-smokers to be binge drinkers4
 Significant correlations have been found between
reported urges to smoke and urges to drink during
exposure to alcoholic beverages in the lab5,6

Genetics/Biochemistry
 There is a substantial genetic correlation between
alcohol and nicotine use and dependence7,8
 There are several possible mechanisms for
alcohol/tobacco links including evidence that
smoking is associated with diminishing effects of
alcohol9 and an association between alcohol
dependence and greater nicotine withdrawal10
 A number of candidate genes may underlie both
alcohol and nicotine dependence (e.g., alpha 4
nicotinic receptor gene)11
 Several neurtransmitters and receptors are
involved in both alcohol and nicotine effects
including GABA12, dopamine13, serotonin14 and
endogenous opioids15, these systems also likely
influence risk of alcohol and nicotine dependence

Potential Treatment Implications
 NRT is the primary pharmacotherapy for smoking
cessation
 Therefore, it is important to know whether NRT is
efficacious for use in the large population of smokers
who are heavy drinkers and those with past or current
alcohol use disorders
 Findings from NRT trials may not be generalizable to
those with past/current alcohol use disorders due to
exclusion criteria in place in clinical trials
 If these findings are generalizable, they could help to
determine what effect, if any, alcohol use status has on
likelihood of smoking cessation
 Findings from these trials could also help to address the
issue of whether nicotine and alcohol use are
substitutable or complementary substances

The Present Study
Given the genetic/biochemical commonalities
underlying smoking and drinking and the treatment
implications of co-morbidity, we conducted a literature
review to assess the following three issues:
1. The generalizability of findings in the NRT literature
to heavy drinking smokers and those with current or
past alcohol use disorders
2. The extent to which alcohol status affects smoking
cessation outcome
3. The likelihood that smoking cessation will result in a
reduction or increase in alcohol use

Method
 We reviewed reports of nicotine replacement trials
published in peer reviewed journals that were
included in the recent Cochrane meta-analysis16
 We looked for presence/absence of alcohol-related
inclusion/exclusion criteria, type of criteria and clarity
with which criteria were described
 In addition, we searched for information about the
impact of alcohol status on smoking cessation
outcome and for reported effects of smoking cessation
on drinking behavior in the course of trials

Criteria for Inclusion in Review
 Comparison between NRT and placebo or
no treatment or between different doses of
NRT
 Post-treatment follow-up had to be at least
6 months
 Cessation rates had to be reported for trials
to be included
 Only reports published in peer-reviewed
journals were included
 Our review covers the trials published
between 1992 and March 2004 that were
included in the Cochrane Report

Results
 Of 69 reports published in peer reviewed
journals during this time period that were
included in the Cochrane meta-analysis, 68
were included in the present review (one report
could not be located)
 Including reports of trials making use of
multiple treatment modalities, the most
common modality was the patch (utilized in 45
trials), followed by the gum (15 trials), inhaler
(10 trials), spray (7), tablet (2) and the
lozenge (1)

Alcohol-Related
Inclusion/Exclusion Criteria
 Alcohol-related exclusion or inclusion
criteria were reported in 35 of the 68
trials (51%)
 Only one paper reported alcoholrelated inclusion criteria, the rest
reported exclusion criteria only

Type of Criteria

Types of Exclusion Criteria
Number of trials
(percentage of the 34
w/exclusion criteria)

Alcohol abuse—
past or present

20 (59%)

Alcohol
dependence only—
past or present

10 (29%)

Other1

4 (12%)

1Alcohol

problems of some kind (2), presence of an unstable alcohol
disorder and alcohol misuse (1 each)

Clarity of Inclusion/Exclusion
Criteria
 In 60% of trials reporting alcohol-related
inclusion/exclusion criteria, there was
ambiguity1 in description of criteria
 In the 13 reports with clear exclusion
criteria, time stipulations were as follows:
no history whatsoever (2), the past year
(5), the past six months (2), current/active
disorder (4)
Ambiguity meaning lack of clarity with respect to the substances in question, the time frame
being evaluated (e.g., lifetime, past six months) and/or the precise criteria being utilized
1

Effects of Alcohol Status on
Smoking Cessation
Two studies provided findings regarding
effects of alcohol status on smoking cessation
 Croghan et al. (2003) reported no difference in
smoking abstinence in a patch/spray trial based
on lifetime alcohol dependence status
 Hughes et al. (2003) reported findings with the
patch in a sample of smokers with a history of
alcohol dependence that closely resembled
results from a prior trial in a sample that was
otherwise similar but without a dependence
history

Effects of Smoking Cessation on
Alcohol Use
Only one of the studies reported
findings concerning effects of smoking
cessation on alcohol use:
Hughes and colleagues (2003) found
that in a sample of smokers with a past
history of alcohol dependence, none of
the participants relapsed to an alcohol
use disorder while quitting smoking

Other Findings
 Patterson et al. (2003) reported that
alcohol use at baseline did not predict
attendance at sessions for a
patch/spray trial
 Wisborg et al. (2000) reported that
pregnant smokers who enrolled in
their patch trial did not differ in level
of alcohol use from those who
expressed interest but did not enroll

Discussion
 Slightly over half of the trials reviewed reported
alcohol-related inclusion/exclusion criteria
 Abuse was the most common exclusion criterion
 Alcohol-related inclusion/exclusion criteria were
described ambiguously in a high proportion of reports
 Only 4 of the papers included in this review reported
any data regarding associations between smoking and
alcohol use
 Given recent interest in links between smoking and
alcohol use, this trend of infrequent reporting may
have improved since the end of the most recent
Cochrane meta-analysis of NRT upon which this
review was based (i.e., April 2004 to the present)

Future Directions for Review
 Papers published in 1991 and earlier
that were included in the Cochrane
meta-analyses will be added to the
review
 Papers published since the cutoff date
for the Cochrane meta-analysis
(March 2004) will be added as well
 The review will also be expanded to
include bupropion trials

Conclusions
-Exclusion of individuals with a past or current history of an
alcohol use disorder may limit the generalizability of results
from NRT trials to this substantial population of smokers
-Only 2 published papers included in this review examined
effects of alcohol use status on smoking cessation
-Based on this review, it is not possible to come to a
conclusion about effects of smoking cessation on alcohol use
-Future studies should incorporate measures of alcohol use
at intake and during treatment in order to evaluate the
generalizibility of results to those with varying alcohol use
statuses and to improve our understanding of reciprocal
relationships between alcohol use and smoking
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